**Core Concept**
Vaccination of patients with chemotherapy-induced complete febrile neutropenia is crucial to prevent infections. The Centers for Disease Control and Prevention (CDC) and the Advisory Committee on Immunization Practices (ACIP) recommend specific vaccinations for such patients to reduce the risk of vaccine-preventable diseases.

**Why the Correct Answer is Right**
The correct answer involves administering live attenuated vaccines (LAVs) to febrile neutropenic patients. The primary concern with LAVs in immunocompromised individuals is the risk of vaccine strain infection. However, in the case of febrile neutropenic patients, the risk of disease from vaccine-preventable infections outweighs the risk of vaccine strain infection. Therefore, live attenuated vaccines such as MMR, varicella, and oral poliovirus vaccine (OPV) can be administered.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is likely to be incorrect as it does not specify the type of vaccine that can be administered to febrile neutropenic patients.

**Option B:** Inactivated vaccines (IVs) such as inactivated influenza vaccine (IIV) are safe to administer to febrile neutropenic patients. However, the question specifies "all are essential," which implies the inclusion of live attenuated vaccines.

**Option C:** This option is incorrect as it is too broad and does not specify the type of vaccines that can be administered to febrile neutropenic patients.

**Clinical Pearl / High-Yield Fact**
Febrile neutropenic patients should receive the appropriate vaccinations as soon as possible, ideally before the onset of neutropenia, to maximize the immune response and reduce the risk of vaccine-preventable infections.

**Correct Answer: D**